Table.
Clinical Characteristics
| HF | LVAD | OHT | p-value | |
|---|---|---|---|---|
| Number of participants | 32 | 44 | 25 | |
| Age (years) | 62.8±11.9 | 58.8±10.7 | 54.1±10.9 | 0.016 |
| Female (%) | 31 | 27 | 24 | 0.829 |
| Black race (%) | 34 | 41 | 32 | 0.422 |
| Left Ventricular Ejection Fraction (%) | 27.3±9.1 | --- | 59.6±8.4 | <0.001 |
| Days Post Implant (Median) | --- | 295.0±479.2 | 311.0±1257.9 | 0.100 |
| BMI (kg/m2) | 32.7±13.9 | 30.7±7.6 | 28.1±4.7 | 0.217 |
| eGFR (ml/min*1.73m2) | 68.7±20.6 | 59.6±24.5 | 65.8±21.9 | 0.208 |
| Dilated Cardiomyopathy (%) | 53 | 59 | 44 | 0.482 |
| Ischemic Cardiomyopathy (%) | 41 | 43 | 40 | 0.959 |
| Myocarditis (%) | 0 | 2 | 12 | 0.052 |
| Hypertension (%) | 56 | 46 | 52 | 0.640 |
| Diabetes mellitus (%) | 22 | 36 | 48 | 0.115 |
| Dyslipidemia (%) | 50 | 50 | 56 | 0.873 |
| NYHA HF Class (%) | <0.001 | |||
| 1 | 3 | 9 | --- | |
| 2 | 22 | 70 | --- | |
| 3 | 69 | 21 | --- | |
| 4 | 0 | 0 | --- | |
| Heart rate (beats/min) | 78.1±17.5 | 83.0±16.9 | 95.1±11.8 | 0.001 |
| Mean Arterial Pressure (mmHg) | 88.3±14.7 | 84.4±17.6 | 96.2±11.1 | 0.011 |
| Pulse Pressure (mmHg) | 49.6±15.7 | 29.8±8.8 | 47.0±9.7 | <0.001 |
| Hemoglobin (mg/dL) | 12.7±1.7 | 11.5±1.7 | 12.8±1.7 | 0.002 |
| B-type natriuretic peptide (ng/L) | 3025.3±3492.0 | 2345.6±1996.1 | --- | 0.371 |
| Total cholesterol (mg/dL) | 173.0±55.2 | 135.4±47.3 | 166.9±35.8 | 0.010 |
| HDL (mg/dL) | 51.9±24.3 | 34.3±14.1 | 46.2±14.8 | 0.003 |
| LDL (mg/dL) | 95.4±44.0 | 74.9±35.1 | 93.3±29.4 | 0.096 |
| INR | 1.6±0.7 | 1.8±0.5 | 1.1±0.1 | <0.001 |
| Platelet count (#/µL) | 225.3±63.2 | 223.6±71.7 | 193.0±72.2 | 0.150 |
| Statin (%) | 44 | 59 | 96 | <0.001 |
| Warfarin (%) | 44 | 93 | 4 | <0.001 |
| ACE-I/ARB (%) | 84 | 46 | 12 | <0.001 |
| Anti-platelets (%) | 53 | 90 | 52 | <0.001 |